Clinuvel Pharm Ords (CLVLF) 2.1000 $CLVLF Vitiligo

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Clinuvel Pharm Ords (CLVLF) 2.1000 $CLVLF

Vitiligo Therapeutics Pipeline Review, H1 2015 - 6 Companies & 7 Drug Profiles
M2 - Wed Jun 24, 10:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dh68bp/vitiligo) has announced the addition of the "Vitiligo - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Vitiligo, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vitiligo and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Ache Laboratorios Farmaceuticos S/A - Biocon Limited - Bristol-Myers Squibb Company - Clinuvel Pharmaceuticals Limited - Reliance Life Sciences Pvt. Ltd. - Sun Pharma Advanced Research Company Ltd. Drug Profiles - abatacept (recombinant) - ACH-24 - afamelanotide - Gene Therapy to Activate SOX9 for Vitiligo and Melanoma - itolizumab - ReliDerm-M - SUN-0597 For more information visit http://www.researchandmarkets.com/research/dh68bp/vitiligo
BMY: 61.44 (+0.93)

Actinic (Solar) Keratosis Pipeline Review, H1 2015
M2 - Fri Jun 12, 4:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vkb4rv/actinic_solar) has announced the addition of the "Actinic (Solar) Keratosis - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Actinic (Solar) Keratosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Actinic (Solar) Keratosis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Mentioned - 3M Drug Delivery Systems - Advancell - Biofrontera AG - Clinuvel Pharmaceuticals Limited - Digna Biotech, S.L. - Dolorgiet Gmbh & Co. Kg - Foamix Pharmaceuticals Ltd. - G&E Herbal Biotechnology Co., Ltd. - Galderma S.A. - Kinex Pharmaceuticals, LLC - LEO Pharma A/S - Novartis AG - Novelix Pharmaceuticals, Inc. - Promius Pharma, LLC - RestorGenex Corporation - Spherium Biomed S.L. For more information visit http://www.researchandmarkets.com/research/vk...inic_solar
FOMX: 6.84 (+0.17), NVS: 91.90 (-0.71)

Global Pemphigus Pipeline Report 2015 - 7 Companies & 10 Drug Profiles
M2 - Thu May 21, 6:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l4jpj9/pemphigus) has announced the addition of the "Pemphigus - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Pemphigus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pemphigus and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Clinuvel Pharmaceuticals Limited - Genmab A/S - HanAll Biopharma Co., Ltd. - Immunomedics, Inc. - Momenta Pharmaceuticals, Inc. - Novartis AG - PinCell srl Drug Profiles - afamelanotide - Antibody for Autoimmune Disorders and Inflammation - DP-C006 - Drugs to Target HSP27 for Autoimmune Disorders - HL-161 - ofatumumab - PC-111 - VAY-736 - veltuzumab - Pemphigus For more information visit http://www.researchandmarkets.com/research/l4jpj9/pemphigus
IMMU: 2.17 (+0.12), MNTA: 16.54 (-0.18), NVS: 91.90 (-0.71)

Vitiligo - Pipeline Review, H1 2014
M2 - Thu Dec 18, 3:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/sp334p/vitiligo) has announced the addition of the "Vitiligo - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Vitiligo, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vitiligo and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Vitiligo - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Vitiligo pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Companies Mentioned: - Reliance Life Sciences - Biocon Limited - Galderma - Sun Pharmaceutical Industries - Clinuvel Pharmaceuticals - Ache Laboratorios Farmaceuticos - SWITCH Biotech For more information visit http://www.researchandmarkets.com/research/sp334p/vitiligo

Market Maker Surveillance Report. RITT, GNI, GTI, GLYC, CLVLY, PULS, Losing Stocks With Lowest Price Friction For Friday, September 26th 2014
M2 - Mon Sep 29, 2:48AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 4860 companies with "abnormal" market making, 3007 companies with positive Friction Factors and 1840 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Friday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Rit Technologies Ltd (NASDAQ:RITT), Great Northern Iron Ore Properties (NYSE:GNI), Graftech International Ltd (NYSE:GTI), GLYCOMED INC (NASDAQ:GLYC), Clinuvel Pharmaceuticals Ltd (OTC:CLVLY), Pulse Electronics Corp (NYSE ULS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
GLYC: 6.70 (+0.08), GTI: 5.05 (+0.01), RITT: 1.75 (unch), GNI: 8.10 (+0.67)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 108

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 7

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Cargo Drones to Skyrocket with $9.14B Value by 2031

Updated Category News Views 87

Riding the Drone Wave I tell you what, folks, the whole business of cargo drones is getting frickin' interesting. These flying gizmos, once dismissed as science fiction, are now barging their way into logistics discussions like an uninvited guest who's too worthwhile to ignore. MarketsandMarkets™ reckons this market's about to smash through the $9 billion ceiling by...

Continue Reading
IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 22

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
NCPDP Elevates J.W. Hill to President & COO Role

Updated Category News Views 9

Plotting the Course for NCPDP's Future Today's shakeup at the NCPDP has got the sector's ears perked. For those who don't speak in acronym soup all day—NCPDP stands for National Council for Prescription Drug Programs. They're the brains behind many crucial healthcare standards, improving information flow around meds, supplies, and services. Now, they're taking bold...

Continue Reading
Cinmoore's Smart Camera: A Game Changer for Car Security

Updated Category News Views 43

Pioneering Car Security with Cinmoore's Smart Camera Ever left your car in the parking lot, heart pounding, wondering if it's safe while you run errands? Well, Cinmoore might just quell that parking paranoia with their new gizmo, the Smart Parking Camera DC1U. This device isn't just some fancily-packaged disappointment—it promises some serious peace of mind for those...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 211

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Inventor Launches Handy Solution for Kids' Car Sickness

Updated Category News Views 0

A Fresh Take on an Age-Old Problem Just when you thought the universe had thrown all it could at beleaguered parents, here comes a nifty little accessory tackling those dreaded uphill battles with kids and car rides. Some bright spark from Middleburgh, New York, sick of scrubbing car seats and clothing every other road trip, came up with a clever little invention named...

Continue Reading
KuCoin Unveils $1.1M USDT Black Friday Bonanza

Updated Category News Views 110

KuCoin's Festive Fireworks: Black Friday Bonanza Sometimes the crypto world feels like a carnival, and KuCoin's latest act is the $1.1 million USDT prize pool, rolling out as part of its 'Tis The Season holiday campaign. A move that matches the glitz of Tomorrowland Winter experiences, adding more sparkle to the crypto stage. Behind the Scenes of the KuCoin-Tomorrowland...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 22

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading

Top 5 Most Recently Viewed Articles

Warren Buffett's Wisdom: Rethinking Your Stock Strategy

Updated Category News Views 155

Billionaire investor Warren Buffett became a titan in finance through his distinctive approach to stock investing, one that flips conventional wisdom on its head. While most folks lose their heads when prices drop, Buffett sees opportunity. When stocks go down, he doesn’t cry; he gets excited. "I love it when the things we buy go down," he said in a reflective moment...

Continue Reading
Kenneth L Calloway's $452K Share Sale: What It Means for CENX

Updated Category News Views 220

Understanding the Recent Insider Trade in Century Aluminum In a notable move that has caught the attention of investors, Kenneth L Calloway, the Senior Vice President at Century Aluminum, recently sold a significant amount of stocks. The transaction, which took place recently and is detailed in an SEC filing, involved the sale of 16,450 shares valued at approximately...

Continue Reading
Jura Energy Corporation Releases Key Financial Information

Updated Category News Views 213

Jura Energy Corporation Financial Filings Overview Jura Energy Corporation has recently announced an important update regarding its financial performance. The company has filed its condensed consolidated interim financial statements for the periods ending June 30 for both 2025 and 2024 on SEDAR. Alongside these financial statements, Jura has also released its...

Continue Reading
Exploring the Surge in Edge Computing Growth and Its Impact

Updated Category News Views 207

Understanding Edge Computing Growth Dynamics The edge computing market is poised for significant growth, projected to increase by USD 19.6 billion during the period between 2024 and 2028. This advancement is primarily fueled by the rising demand for decentralized computing, aimed at minimizing latency in decision-making processes. Technological advancements heralding...

Continue Reading
Hiab's Q3 Report 2025: Navigating Challenges with Resilience

Updated Category News Views 239

Hiab's Financial Journey in Q3 2025: An Overview Hiab's latest quarterly report sheds light on the company's performance amidst swirling market uncertainties. The recent challenges stemmed primarily from lower sales figures in parts of their market, particularly in the United States, affecting profitability. Key Highlights of the Quarterly Performance The first major...

Continue Reading